Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
March 20th, 2017
11.9K views
Bariatric surgery is the most efficient way to reduce body weight and the deadly metabolic complications (diabetes, obesity, and dyslipidemia) frequently associated with morbid obesity. Mouse models of bariatric surgery represent a unique asset for deciphering molecular mechanisms behind the beneficial effects of these surgeries on diabetes, hypertension, and dyslipidemia.
Overview
Bariatric surgery is an effective intervention for reducing body weight and associated metabolic complications. This study utilizes mouse models to explore the molecular mechanisms underlying the benefits of these surgeries on conditions like diabetes and dyslipidemia.
Key Study Components
Area of Science
- Neuroscience
- Metabolism
- Obesity Research
Background
- Bariatric surgery is linked to significant metabolic improvements.
- Mouse models provide insights into the effects of surgical interventions.
- Understanding these mechanisms can inform clinical practices.
- Research focuses on conditions such as diabetes and hypertension.
Purpose of Study
- To measure metabolic effects of sleeve gastrectomy and Roux-en-Y bypass.
- To investigate molecular pathways involved in metabolic gains.
- To simulate clinical outcomes observed in human patients.
Methods Used
- Mouse models are used to replicate bariatric surgery effects.
- Procedures include anesthesia and surgical techniques.
- Metabolic assessments are conducted post-surgery.
- Data is analyzed to understand molecular mechanisms.
Main Results
- Demonstrated metabolic improvements following surgery.
- Identified key molecular pathways involved in these changes.
- Validated mouse model findings against human clinical data.
- Provided insights into obesity-related health issues.
Conclusions
- Bariatric surgery has significant metabolic benefits.
- Mouse models are effective for studying these interventions.
- Further research is needed to explore long-term effects.
Frequently Asked Questions
What is the main goal of this study?
The main goal is to measure the metabolic effects of bariatric surgery in mouse models.
How does the mouse model relate to human patients?
The mouse model simulates the clinical consequences of bariatric surgery observed in humans.
What are the two types of surgeries studied?
The study focuses on sleeve gastrectomy and Roux-en-Y bypass.
What are the expected outcomes of the surgeries?
Expected outcomes include improvements in diabetes, hypertension, and dyslipidemia.
Why are mouse models used in this research?
Mouse models allow for controlled studies of metabolic changes post-surgery.
What is the significance of understanding these mechanisms?
Understanding these mechanisms can lead to better treatment strategies for obesity-related conditions.
Executive Industry Relevance
Mouse models of sleeve gastrectomy and modified Roux-en-Y gastric bypass enable systematic investigation of the molecular mechanisms underlying bariatric surgery’s metabolic benefits. These validated procedures provide a translational bridge for target validation and mechanistic de-risking in obesity and metabolic disease research. Their reproducibility and adaptability support early discovery and preclinical pipeline decisions for metabolic target portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of metabolic pathways and therapeutic hypotheses in genetically modified mice.
- Supports functional target validation by modeling human bariatric surgery outcomes in vivo.
- Facilitates mechanistic de-risking for metabolic disease targets through controlled intervention studies.
Screening & Assay Development
- Provides a standardized in vivo system for evaluating metabolic phenotypes post-surgery.
- Enables reproducible measurement of quantitative outputs such as weight loss and glucose tolerance.
- Supports assay readiness for downstream compound screening in metabolic disease models.
Translational & Preclinical Research
- Aligns preclinical models with clinically relevant endpoints observed in human bariatric surgery.
- Enables continuity from discovery through preclinical validation for metabolic and obesity-related targets.
- Supports risk-adjusted advancement decisions by providing predictive in vivo data.
Pipeline & Workflow Integration
These surgical models position within the early discovery to preclinical continuum, enabling hypothesis testing, pathway clarification, and translational validation for metabolic disease research.
- Discovery Biology: Supports null hypothesis testing and mechanistic pathway analysis for metabolic interventions.
- Screening: Delivers reproducible, quantitative readouts for weight loss and metabolic improvement.
- Analytics: Enables statistical comparison of intervention effects across experimental groups.
- Translational Research: Provides disease-relevant models for aligning preclinical findings with clinical outcomes.
- Enterprise Reuse: Offers a reusable platform for evaluating diverse genetic backgrounds and interventions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in metabolic disease research.
- Operational Value: Standardizes surgical and post-operative protocols for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in metabolic target portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of metabolic disease programs.
Implementation Considerations
- Requires advanced surgical expertise and intensive training for reproducibility.
- Demands access to specialized surgical instrumentation and post-operative care infrastructure.
- Necessitates cross-team standardization of protocols and outcome measurements.
- Adaptable to various genetically modified mouse strains for mechanistic studies.
- Post-operative care and monitoring are critical for survival and data integrity.
Biopharma FAQs
Why does null hypothesis testing matter for bariatric surgery models?
Null hypothesis testing in these mouse models enables rigorous evaluation of whether observed metabolic improvements are attributable to surgical intervention rather than confounding variables, supporting robust target validation.
How does independent variable isolation fit the sleeve gastrectomy workflow?
By controlling surgical technique and post-operative care, researchers can isolate the effects of the surgical intervention itself, clarifying the causal relationship between procedure and metabolic outcome.
What do quantitative dependent variable measurements enable in these protocols?
Quantitative measurements such as weight loss and glucose tolerance provide objective endpoints for comparing intervention groups and assessing the efficacy of metabolic targets in vivo.
Why are replication requirements critical for cross-functional metabolic studies?
Replication ensures that observed effects are reproducible across experiments and teams, enabling reliable cross-functional collaboration and data integration in metabolic disease research.
What statistical analysis capabilities are required before implementing these surgical models?
Robust statistical analysis is needed to compare intervention and control groups, assess significance of metabolic changes, and support data-driven advancement decisions in the discovery pipeline.
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg%3Fv%3D2026-08-25T05%253A51%253A25.000Z&w=384&q=75)
